NCT00272350 2019-12-05ZD6474 to Treat Advanced Brain Cancer in PatientsNational Institutes of Health Clinical Center (CC)Phase 1 Completed83 enrolled
NCT00613223 2013-02-20Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant GliomasDuke UniversityPhase 1 Completed49 enrolled
NCT00613054 2012-12-05Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant GliomaDuke UniversityPhase 1 Completed27 enrolled